tirzepatide heart failure fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide cuts heart failure risk

Disclaimer : The information provided is for general informational purposes only and is not intended as medical advice

If you reach 8 to 12mg retatrutide and your results are inferior to what tirzepatide produced, switching back is a reasonable option

Some patients respond better to one mechanism than the other, and tirzepatide may cause different or less severe side effect patterns for certain individuals

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: a 52-week open-label, randomized phase III trial